Mylan N.V. (Nasdaq: MYL) today announced the U.S. launch of Esomeprazole Magnesium Delayed-release Capsules USP, 20 mg and 40 mg, which is the generic version of AstraZeneca's Nexium ®. Mylan received ...

"Dr Reddy's today announced relaunch of its Esomeprazole magnesium delayed-release capsules (20 mg and 40 mg) in the US market," says the pharma major, adding the relaunch is due to a change in ...

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Esomeprazole Magnesium ...

Mahwah: Glenmark Specialty SA (Glenmark) has received final approval from the United States Food and Drug Administration (USFDA) for its Esomeprazole Magnesium delayed-release capsules USP, 20 mg (OTC ...

https://www.thehindubusinessline.com/markets/marksans-receives-usfda-approval-for-esomeprazole-magnesium-capsules/article67374805.ece Copy Marksans Pharma Ltd has ...

PHILADELPHIA, Sept. 5, 2017 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug ...

Marksans Pharma Limited on Tuesday announced that it has received final approval from the US Food & Drugs Administration for its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium ...

https://www.thehindubusinessline.com/markets/glenmarks-unit-gets-usfda-for-esomeprazole-magnesium-delayed-release-capsule/article68280034.ece Copy Glenmark Specialty ...

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated April 22, 2016 titled "Aurobindo Pharma receives USFDA Approval for Esomeprazole Magnesium Delayed-release Capsules".Source : BSE ...

The 20 mg and 40 mg capsules are available in bottle count size of 30 Dr Reddy’s Laboratories (DRL) has launched esomeprazole magnesium delayed-release capsules USP, 20 mg and 40 mg, a therapeutic ...

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (FDA) for esomeprazole magnesium delayed-release capsules USP, 20 mg (OTC), determined by ...

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, 20 mg and 40 mg, a therapeutic equivalent generic version of NEXIUM® ...